Skip to main content
. 2024 Jun 7;28(2):362. doi: 10.3892/ol.2024.14495

Figure 3.

Figure 3.

PSA response rate evaluated in patients who received palliative treatment after PSA progression and no evidence of residual tumour rate evaluated in patients who underwent radical prostatectomy.